Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$8.38 USD
+0.33 (4.10%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $8.38 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $0.13 | 0.00% |
Earnings Summary
For their last quarter, Amneal Pharmaceuticals (AMRX) reported earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This reflects a positive earnings surprise of 14.29%. Look out for AMRX's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of $0.13 per share, reflecting a year-over-year decrease of 31.58%.
Earnings History
Price & Consensus
Zacks News for AMRX
Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia
AMRX: What are Zacks experts saying now?
Zacks Private Portfolio Services